Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach

被引:17
作者
Andreano, Anita [1 ,2 ]
Rebora, Paola [1 ]
Valsecchi, Maria Grazia [1 ]
Russo, Antonio Giampiero [2 ]
机构
[1] Univ Milano Bicocca, Sch Med & Surg, Ctr Biostat Clin Epidemiol, Via Cadore 48, I-20900 Monza, Italy
[2] Agcy Hlth Protect Prov Milan, Epidemiol Unit, Milan, Italy
关键词
Breast cancer care; Adherence to guidelines; Survival; Causal inference; Administrative health databases; Process indicators; COMORBIDITY INDEX; INDICATORS; CHEMOTHERAPY; ASSOCIATION; PERFORMANCE; MANAGEMENT; MORTALITY; DIAGRAMS; OUTCOMES; THERAPY;
D O I
10.1007/s10549-017-4210-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose There is a lack of real-world studies evaluating the impact on survival of an evidence-based pathway of care in breast cancer. The aim of this work is to investigate the effect of adherence to guidelines on long-term survival for a cohort of Italian breast cancer patients. Methods The cohort included incident female breast cancer cases (2007-12), from the registry of the Milan province (Italy), not metastatic at diagnosis and receiving primary surgery. We selected sets of indicators, according to patient and tumor characteristics. We then defined the pathway of care as adherent to guidelines if it fulfilled at least 80% of the indicators. Indicators were measured using different administrative health databases linked on a unique key. A causal inference approach was used, drawing a directed acyclic graph and fitting an inverse probability weighted marginal structural model, accounting for patient's demographic, socioeconomic and tumor characteristics. Results The analysis included 6333 patients, 69% of them were classified as having an adherent care. Mean age was 61 years (standard deviation, 13.6 years) and half of the patients were in Stage I (50%) at diagnosis. Median follow-up time was 5.6 years. Overall, 5-year survival was 90% (95% CI, 89-91%). The estimated risk of death was 30% lower for patients with adherent than nonadherent care (hazard ratio [HR], 0.66; 95% CI, 0.55-0.77). Conclusions Our study confirms, in real-world care, the impact on survival of receiving a care pathway adherent to guidelines in non-metastatic breast cancer patients.
引用
收藏
页码:119 / 131
页数:13
相关论文
共 50 条
  • [1] Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach
    Anita Andreano
    Paola Rebora
    Maria Grazia Valsecchi
    Antonio Giampiero Russo
    Breast Cancer Research and Treatment, 2017, 164 : 119 - 131
  • [2] Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study
    Nayan, Madhur
    Macdonald, Erin M.
    Juurlink, David N.
    Austin, Peter C.
    Finelli, Antonio
    Kulkarni, Girish S.
    Hamilton, Robert J.
    PHARMACOLOGICAL RESEARCH, 2016, 113 : 468 - 474
  • [3] Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer
    Vodermaier, Andrea
    Linden, Wolfgang
    Rnic, Katerina
    Young, Sandra N.
    Ng, Alvina
    Ditsch, Nina
    Olson, Robert
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (02) : 373 - 384
  • [4] Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study
    Badic, Bogdan
    Bouvier, Anne-Marie
    Bouvier, Veronique
    Morvan, Marie
    Jooste, Valerie
    Alves, Arnaud
    Nousbaum, Jean-Baptiste
    Reboux, Noemi
    CANCERS, 2022, 14 (21)
  • [5] Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study
    Liu, Peipei
    McMenamin, Una C.
    Spence, Andrew D.
    Johnston, Brian T.
    Coleman, Helen G.
    Cardwell, Chris R.
    BMC CANCER, 2019, 19 (01)
  • [6] Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer
    Andrea Vodermaier
    Wolfgang Linden
    Katerina Rnic
    Sandra N. Young
    Alvina Ng
    Nina Ditsch
    Robert Olson
    Breast Cancer Research and Treatment, 2014, 143 : 373 - 384
  • [7] Adherence to national guidelines for gastric cancer in the Netherlands: A retrospective population-based audit
    Ho, Vincent K. Y.
    Damhuis, Ronald A. M.
    Hartgrink, Henk H.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1156 - 1161
  • [8] Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
    Lofling, L. Lukas
    Stoer, Nathalie C.
    Andreassen, Bettina Kulle
    Ursin, Giske
    Botteri, Edoardo
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [9] Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain
    Petrova, Dafina
    Redondo-Sanchez, Daniel
    Rodriguez-Barranco, Miguel
    Marcos-Gragera, Rafael
    Guevara, Marcela
    Carulla, Maria
    Lopez de Munain, Arantza
    Vizcaino, Ana
    del Barco, Sonia
    Gonzalez-Flores, Encarnacion
    Pollan, Marina
    Sanchez, Maria-Jose
    BMJ QUALITY & SAFETY, 2024,
  • [10] Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study
    Hill, Deirdre A.
    Prossnitz, Eric R.
    Royce, Melanie
    Nibbe, Andrea
    PLOS ONE, 2019, 14 (10):